AxTalis is a consulting company that focuses on market access, regulatory affairs and medical affairs to support strategies and early launch implementation for academia, pharmaceutical/Biotech and device companies. Our vision is to broaden the perspectives of patients to access drugs in a sustainable manner by collaborating closely with physicians, researchers, companies, payers and patients.
Medical Affairs, Market Access and Regulatory Affairs
Market Access services include strategy development including EU/US Landscaping & pricing, GVD development, reimbursement files, Health economic modelling and outcome research. Flexible staffing allows us to provide temporary FTEs to companies on a time or project basis.
Services for Medical Affairs include medical writing, support for training development and implementation, stakeholder interaction & advisory boards, project development and implementation (early access, data generation/RWE, speaker programs, patient support programs). The creation and production of medical and promotional materials are supported by our ‘RIP’ activity and print service.
Our Regulatory Affairs services include healthcare policy and all aspects related to obtaining and maintaining registration of therapeutic solutions in the EU and US. We also have a dedicated team that supports companies with pharmacovigilance and medical information.
Contact
Sven Tops Managing Partner – Market Access Director
sven.tops@axtalis.com
+32 497 59 40 45
